SCHEMBL19540704

SCHEMBL19540704

CCc1cc(F)ccc1NC[C@@H]1C[C@H](F)CN1C(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ECE1 P42892 1/20 0.40
▸ GPR119 Q8TDV5 1/20 0.39
▸ CYP1A2 P05177 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ ITGA4 P13612 4/20 0.36
▸ ITGB1 P05556 2/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ BRD3 Q15059 2/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ CCR3 P51677 1/20 0.35
▸ APP P05067 1/20 0.35
▸ HTR1A P08908 1/20 0.35
▸ ADRA2A P08913 1/20 0.35
▸ DRD2 P14416 1/20 0.35
▸ ADRA2B P18089 1/20 0.35
▸ ADRA2C P18825 1/20 0.35
▸ SLC6A2 P23975 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19540504 0.88 HDAC2 (0.41) ECE1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL19540705 0.85 MAPT (0.39) GPR119CYP1A2POLBCYP3A4CYP2C19
SCHEMBL29774856 0.81 TGFBR1 (0.40) CYP1A2POLBCYP3A4CYP2C19ITGA4
SCHEMBL1298592 0.74 ALDH1A1 (0.38) ITGA4HDAC8DPP4FAPDPP8
SCHEMBL5152726 0.74 POLB (0.41) POLBHDAC1
SCHEMBL29565864 0.73 LMNA (0.36) CYP1A2POLBCYP3A4CYP2C19HSD11B1
SCHEMBL22670584 0.73 LMNA (0.36) CYP1A2POLBCYP3A4CYP2C19HSD11B1
SCHEMBL22671985 0.73 LMNA (0.36) CYP1A2POLBCYP3A4CYP2C19HSD11B1
SCHEMBL29565667 0.73 LMNA (0.36) CYP1A2POLBCYP3A4CYP2C19HSD11B1
SCHEMBL15060429 0.72 STK17B (0.49) GPR119APPHTR1AADRA2ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017186147-A1 BENZIMIDAZOLE-LINKED INDOLE COMPOUND ACTING AS NOVEL DIVALENT IAP ANTAGONIST 南京明德新药研发股份有限公司 2017-11-02 — — WO disclosed
Send feedback